Literature DB >> 14563953

Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia.

Yutaka Ueda1, Takayuki Enomoto, Takashi Miyatake, Keiichiro Ozaki, Tatsuo Yoshizaki, Hiroyuki Kanao, Yuko Ueno, Ryuichi Nakashima, Kenneth R Shroyer, Yuji Murata.   

Abstract

To define the natural history of cervical intraepithelial neoplasia (CIN) as related to clonal status, we evaluated 20 cases of CIN1 and 18 cases of CIN2 that had been clinically followed for 7 to 48 months at Osaka University Hospital. These included 10 cases that progressed, 15 cases that persisted, and 13 cases that regressed. We analyzed the clonal status of each case by analysis of the pattern of X-chromosomal inactivation. Human papillomavirus (HPV) infection was detected by PCR-RFLP analysis. CINs that are monoclonal or infected by high-risk HPVs are more likely to progress or persist than cases that are polyclonal or negative for high-risk HPVs (p = 0.009 for monoclonal vs polyclonal, p = 0.024 for high-risk HPV positive vs negative p = 0.024). Eighteen (90%) of 20 monoclonal, high-risk HPV-associated CINs progressed or persisted, whereas 9 (60%) of 15 polyclonal or high-risk HPV-negative CINs regressed. Therefore, the combination of clonality status and high-risk type HPV infection was significantly correlated with clinical outcome (p = 0.003). The physical status of the HPV genome was evaluated in 17 cases of HPV-16 positive CINs by real-time PCR. Of those, the HPV viral genome was present in both episomal and integrated forms in 14 CINs (84%), and 12 of these cases (86%) were monoclonal in composition. By contrast, all three CINs in which the HPV genome was present in episomal form were polyclonal. In one CIN1 that was polyclonal, HPV-16 was originally present in episomal form but after 24 months, the patient developed a monoclonal CIN3 in which the HPV-16 genome was present in mixed form. These results may imply that HPV viral integration into the host genomic DNA is associated with progression from polyclonal to monoclonal status in CIN. These events may play a fundamental role in the progression from low-grade to higher grade dysplasia of the cervical mucosa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563953     DOI: 10.1097/01.lab.0000092234.68751.83

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

1.  p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.

Authors:  Giovanni Negri; Fabio Vittadello; Fabio Romano; Armin Kasal; Francesco Rivasi; Salvatore Girlando; Christine Mian; Eduard Egarter-Vigl
Journal:  Virchows Arch       Date:  2004-10-09       Impact factor: 4.064

Review 2.  The role of viral and bacterial pathogens in gastrointestinal cancer.

Authors:  Michael Selgrad; Peter Malfertheiner; Lucia Fini; Ajay Goel; C Richard Boland; Luigi Ricciardiello
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

Review 3.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution.

Authors:  Yusuke Tanaka; Yutaka Ueda; Mamoru Kakuda; Satoshi Kubota; Satoko Matsuzaki; Satoshi Nakagawa; Tomomi Egawa-Takata; Shinya Matsuzaki; Eiji Kobayashi; Kiyoshi Yoshino; Tadashi Kimura
Journal:  Int J Clin Oncol       Date:  2015-12-22       Impact factor: 3.402

5.  Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.

Authors:  Mina Kalantari; Kathryn Osann; Itzel E Calleja-Macias; Seong Kim; Bing Yan; Sara Jordan; Dana M Chase; Krishnansu S Tewari; Hans-Ulrich Bernard
Journal:  Virology       Date:  2013-11-09       Impact factor: 3.616

6.  Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.

Authors:  Hugo Arias-Pulido; Cheri L Peyton; Nancy E Joste; Hernan Vargas; Cosette M Wheeler
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

Review 7.  Human papillomavirus infections: warts or cancer?

Authors:  Louise T Chow; Thomas R Broker
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

8.  Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.

Authors:  S-M A Kulmala; S M Syrjänen; U B Gyllensten; I P Shabalova; N Petrovichev; P Tosi; K J Syrjänen; B C Johansson
Journal:  J Clin Pathol       Date:  2006-02-16       Impact factor: 3.411

9.  Two distinct pathways to development of squamous cell carcinoma of the vulva.

Authors:  Yutaka Ueda; Takayuki Enomoto; Toshihiro Kimura; Kiyoshi Yoshino; Masami Fujita; Tadashi Kimura
Journal:  J Skin Cancer       Date:  2010-09-28

10.  Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer.

Authors:  S L Cooke; J Temple; S Macarthur; M A Zahra; L T Tan; R A F Crawford; C K Y Ng; M Jimenez-Linan; E Sala; J D Brenton
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.